Table 1B.
TSA | 12 h | 24 h | 48 h | 72 h | control |
---|---|---|---|---|---|
37.5 ng/ml | 1.14 ± 0.12 | 1.13 ± 0.04 | 1.12 ± 0.03 | 1.11 ± 0.06 | 1.15 ± 0.07 |
75 ng/ml | 1.12 ± 0.06 | 1.09 ± 0.08 | 0.93 ± 0.071 | 0.75 ± 0.132 |
p = 0.02 vs control;
p = 0.005 vs control;
The treatment with TSA at 75 ng/ml for 48 and 72 h resulted in a significant decrease in SGC-7901 cell viability compared to the control group.